Pediatric Patients Having Renal Failure and on Regular Hemodialysis Clinical Trial
Official title:
Effects of Curcumin on Inflammation and Oxidative Stress in Paediatric Patients on Regular Hemodialysis: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
- The study will be a randomised, double blinded, placebo controlled design. - It will include 2 groups : trial group and placebo group - Patients in both groups are children on regular hemodialysis - The patients in the trial group will receive Curcumin capsule 1 gm for 3 months , and the placebo group will receive a placebo capsule for 3 months - All patients will be evaluated clinically, and laboratory at baseline, at 3 months after end of supplementation.
n/a